The Leukemia & Lymphoma Society (LLS) Data at ASH Provides Glimpse into the Future of Blood Cancer Treatment
New data from LLS first-of-its-kind master clinical trials — Beat AML® and Pediatric Acute Leukemia (PedAL) — show promise for hard-to-treat leukemias